Doctors in the UK have found that high blood thinners reduce the lung failure caused by the side effects of the virus
Significant breakthrough in the treatment of coronary virus severe patients: After a comprehensive set of tests for the severely ill patients mainly suffering from lung failure, the British Health Service (HNS) experts concluded that one of the effective ways to treat the effects of the disease is by blood thinners that prevent clotting.
Photo: Shmuel Buchris
Patients with CT scans of the virus found that the main cause of lung failure was due to clotting and clogging of the small blood vessels, following blood clots caused by the virus. According to Professor Peter Offenshaw, a senior member of the state's emergency medical advisory team, "Widespread collaboration among the disease-treating agents has exposed us to surprising and more accurate information about it. What we have seen repeatedly in patients' reviews is that the virus does not get enough oxygen in the blood vessels. Because of the clogging of the small blood vessels, the blood clots are healthy. "
In light of the discovery, in the coming days the British HNS will guide teams treating the severely ill to begin giving them anticoagulants as part of the virus fight to save their lives. However, it is a treatment method that has a risk factor because of the relatively large amount of anticoagulants that can lead to internal blood flow. Dr. Birgish Patel, of the Royal Brompton Hospital and a doctor at the Imperial Hospital, says: "Obviously, providing a significant amount of blood thinners will help difficult patients to overcome the disease. But it must be done correctly to prevent future damage. "